Akèy › Gliyoblastòm › Nebraska
Etid klinik pou Gliyoblastòm nan Nebraska
5 etid pou Gliyoblastòm ap chèche patisipan nan sit nan Nebraska.
Vil nan Nebraska
Tèks ofisyèl etid la (Anglè)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Nebraska Medical Center, Omaha
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
- University of Nebraska Medical Center, Omaha
Ap rekriteFaz 1
Laj 19 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05698524Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT05283330Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
- University of Nebraska Medical Center, Omaha
Ap rekriteFaz 1/2
Laj 19 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06011109SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Omaha
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.